GlassScriptPhysician profile
Melanie Snyder
NPI 1487069605
$1,896.24
in general payments reported to CMS, 2019-2025
17 companies · $180 in 2025
The $180 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $668 · 2022: $460 · 2023: $184 · 2024: $405 · 2025: $180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $769.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $768.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $387.29 | 2021-2025 | |
| Journey Medical Corporation | $362.92 | 2022-2024 | |
| Janssen Biotech, INC. | $170.76 | 2021-2025 | Tremfya |
| Sun Pharmaceutical Industries INC. | $135.06 | 2021-2024 | Winlevi, Absorica Ld |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $130.95 | 2021-2024 | Jublia, Cabtreo |
| Almirall LLC | $124.97 | 2024 | Klisyri |
| E.R. Squibb & Sons, L.L.C. | $118.20 | 2022 | |
| Lilly USA, LLC | $86.58 | 2021-2025 | Taltz, Olumiant, Ebglyss |
| Medimetriks Pharmaceuticals, INC. | $60.87 | 2025 | |
| Ucb, INC. | $59.94 | 2022-2023 | Bimzelx, Cimzia |
| Incyte Corporation | $49.99 | 2024-2025 | Opzelura |
| Novartis Pharmaceuticals Corporation | $46.56 | 2022-2023 | |
| Genzyme Corporation | $43.22 | 2023 | |
| Galderma Laboratories, L.P. | $37.34 | 2021-2025 | Nemluvio |
| Leo Pharma INC. | $32.45 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $32.21 | 2021-2022 | |
| Arcutis Biotherapeutics, INC. | $16.93 | 2024 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melanie Snyder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.